Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 2025

Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 2025 GlobeNewswire September 08, 2025 EB613 Demonstrates Significant Effects on Both Trabecular and Cortical Bone Compartments After Just 6 Months of Treatment in Phase 2 Study; Cortical Improvements Comparable to Injectable Teriparatide and Abaloparatide Company […]

Telos Corporation, an Official TSA PreCheck(R) Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations

Telos Corporation, an Official TSA PreCheck(R) Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations New enrollment locations offer convenient options for consumers to enroll in TSA PreCheck at Office Depot stores and other partner locations in 41 U.S. states and territories. GlobeNewswire September 08, 2025 ASHBURN, Va., Sept. 08, 2025 (GLOBE NEWSWIRE)

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments GlobeNewswire September 08, 2025 Expands investment in givastomig in 1L metastatic gastric cancers, with plans to initiate a global randomized Phase 2 study in combination with immunochemotherapy, in Q1 2026, with additional Phase 1b cohorts to follow Reiterates expectations to report topline givastomig Phase 1b dose

UMeWorld Expands Growth Strategy with DAGola China Launch, Biofuel Pilot Plant, and Future SAF Potential

UMeWorld Expands Growth Strategy with DAGola China Launch, Biofuel Pilot Plant, and Future SAF Potential GlobeNewswire September 08, 2025 MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) — UMeWorld Limited (OTC: UMEWF), a public company engaged in functional nutrition and sustainable biofuel innovation, today provided a comprehensive corporate update. UMeWorld operates a dual-growth platform powered by a

REPEAT: CleanCore Solutions Announces Closing of $175,000,420 Private Placement

REPEAT: CleanCore Solutions Announces Closing of $175,000,420 Private Placement GlobeNewswire September 08, 2025 Establishes the official Dogecoin Treasury of the Dogecoin Foundation and its Newly Established Corporate Arm, the House of Doge The transaction consisted of marquee institutional and crypto native investors including, but not limited to, MOZAYYX, Pantera, GSR, FalconX and Borderless OMAHA, Neb.,

Zeo Energy Corp. to Present at ROTH Capital’s Solar & Storage Symposium at RE+ 25 on September 9, 2025

Zeo Energy Corp. to Present at ROTH Capital's Solar & Storage Symposium at RE+ 25 on September 9, 2025 GlobeNewswire September 08, 2025 NEW PORT RICHEY, Fla., Sept. 08, 2025 (GLOBE NEWSWIRE) — Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions,

CorMedix Announces Strategic Minority Investment in Talphera

CorMedix Announces Strategic Minority Investment in Talphera GlobeNewswire September 08, 2025 BERKELEY HEIGHTS, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it has made a $5 million strategic minority equity investment in Talphera,

Pelthos Therapeutics to Participate in Upcoming September Investor Conferences

Pelthos Therapeutics to Participate in Upcoming September Investor Conferences GlobeNewswire September 08, 2025 DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel II,

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to October 9, 2025

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to October 9, 2025 GlobeNewswire September 08, 2025 New York, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) — Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company“), a special purpose acquisition company, announced today that on September 4, 2025,

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company GlobeNewswire September 08, 2025 CHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today

Scroll to Top